Mechanistic Insights into the Anti-Proliferative Action of Gut Microbial Metabolites against Breast Adenocarcinoma Cells
Open Access
- 10 October 2023
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (20) , 15053
Abstract
The gut microbiota undergoes metabolic processes to produce by-products (gut metabolites), which play a vital role in the overall maintenance of health and prevention of disease within the body. However, the use of gut metabolites as anticancer agents and their molecular mechanisms of action are largely unknown. Therefore, this study evaluated the anti-proliferative effects of three key gut microbial metabolites—sodium butyrate, inosine, and nisin, against MCF7 and MDA-MB-231 breast adenocarcinoma cell lines. To determine the potential mechanistic action of these gut metabolites, flow cytometric assessments of apoptotic potential, reactive oxygen species (ROS) production measurements and proteomics analyses were performed. Sodium butyrate exhibited promising cytotoxicity, with IC50 values of 5.23 mM and 5.06 mM against MCF7 and MDA-MB-231 cells, respectively. All three metabolites were found to induce apoptotic cell death and inhibit the production of ROS in both cell lines. Nisin and inosine indicated a potential activation of cell cycle processes. Sodium butyrate indicated the possible initiation of signal transduction processes and cellular responses to stimuli. Further investigations are necessary to ascertain the effective therapeutic dose of these metabolites, and future research on patient-derived tumour spheroids will provide insights into the potential use of these gut metabolites in cancer therapy.Keywords
Funding Information
- Open Access funding support from NICM Health Research Institute, Western Sydney University, Australia
This publication has 78 references indexed in Scilit:
- Prosaposin, a regulator of estrogen receptor alpha, promotes breast cancer growthCancer Science, 2012
- Butyrate Histone Deacetylase InhibitorsBioResearch Open Access, 2012
- Prosaposin inhibits tumor metastasis via paracrine and endocrine stimulation of stromal p53 and Tsp-1Proceedings of the National Academy of Sciences, 2009
- Identification of a Novel Microtubule-destabilizing Motif in CPAP That Binds to Tubulin Heterodimers and Inhibits Microtubule AssemblyMolecular Biology of the Cell, 2004
- P21WAF1/CIP1 is dispensable for G1 arrest, but indispensable for apoptosis induced by sodium butyrate in MCF-7 breast cancer cellsOncogene, 2004
- Sodium Butyrate Induces G2 Arrest in the Human Breast Cancer Cells MDA-MB-231 and Renders Them Competent for DNA RereplicationExperimental Cell Research, 1999
- On the Regulation and Function of Human Polo-like Kinase 1 (PLK1): Effects of Overexpression on Cell Cycle ProgressionBiochemical and Biophysical Research Communications, 1997
- Butyrate modulates DNA-damage-induced p53 response by induction of p53-independent differentiation and apoptosisOncogene, 1997
- Effect of sodium butyrate on human breast carcinoma (MCF-7) cellular proliferation, morphology, and CEA productionBreast Cancer Research and Treatment, 1984
- Associated effects of sodium butyrate on histone acetylation and estrogen receptor in the human breast cancer cell line MCF-7Biochemical and Biophysical Research Communications, 1984